未找到相关数据
Surufatinib plus sintilimab in patients with advanced gastric/gastroesophageal junction adenocarcinoma (GC/GEJC): A single-arm, open-label, single-center phase II trial.
被引：0
作者：
Zhang, Dong-Sheng
Liu, Fu-Rong
Lu, Yun-Xin
Bai, Bing
Zhang, Yang
Wang, Zhi-Qiang
Liu, Yu
Chen, Jian-Wen
Wang, Feng
Xu, Rui-Hua
机构：
[1] Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,State Key Lab Oncol South China, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Clin Res,State Key Lab Oncol South China, Guangzhou, Peoples R China
关键词：
613-135-244-3829-325;
130-540-543-4790;
130-540-543-12277-2683;
261-492-5651-9270-10662;
298-145-222-184-4809-5347;
298-145-222-184-1022-9124;
613-615-646-4685-3986;
6;
3;
2;
4062;
1704;
2444;
1597;
4;
1;
38116-38094-8;
38092-34311;
38092-21759;
D O I：
10.1200/JCO.2024.42.3_suppl.358
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：358 / 358
页数：1
相关论文